Epidemiological, Clinical and Therapeutic Aspects of Atopic Dermatitis in the Dermatovenerology Department of the National References University Teaching Hospital of N’Djamena (Chad): About 103 Cases
Introduction: Atopic dermatitis is a chronic inflammation of the skin. The diagnosis is clinical and based on the United Kingdom Working Party criterion led by Williams. The aim of this study is to contribute to the management of atopic eczema within the dermatovenerology department of the CHU-RN of N’Djamena. Material and Method: This was a descriptive and analytical retrospective study carried out over a period of 12 months (January 2019 to December 2019). Included were all patients diagnosed with Atopic dermatitis in the dermatovenerology department of the University Hospital Center of the National Reference of N’Djamena. Data analysis was performed with SPSS 18.0 software. Results: The study included 602 patients. The diagnosis of AD was retained in 38 patients with a prevalence of 6.3%. The average age was 10.84 years (0 to 25 years). A female predominance (sex-ratio F/M = 1.2). The Atopic dermatitis had started before 2 years in the 38 patients, 39.5% before 15 years and 60.5% after 15 years. Familial atopy was statistically associated with AD (P = 0.004). Inbreeding was statistically associated with Atopic dermatitis (P = 0.002). Lichenification was more represented (78.9%) followed by cutaneous xerosis. The wrists and hands were the most affected respectively in 23.7% and 21.1% of cases. The study showed bacterial superinfection in 31 patients (81%) and only 1 case (2.6%) of viral superinfection. Topical corticosteroids and emollients were used in 95% and 74% of cases respectively. Antihistamines in 92% of cases, antibiotics were necessary in 58% by local application and 29% by the enteral route. Conclusion: Although the frequency is high in this study, it remains low compared to other studies, which makes it possible to classify Chad among the countries of medium prevalence. However, in-depth studies at the national level including the triggering factors will be necessary.
References
[1]
Muller, Q., Berthod, F. and Flacher, V. (2021) Tridimensional in Vitro Models of Nervous and Immune Systems in the Skin. Medical Sciences, 37, 68-76. https://doi.org/10.1051/medsci/2020260
[2]
Koudoukpo, C., Akpadjan, F., Agbessi, N., Dégboé, B., Nouhoumon, G., Adégbidi, H., et al. (2019) Aspects Épidémiologiques de la dermatite atopique au CHU borgou-alibori de parakou (Benin). Health Sciences and Disease, 20.
[3]
Just, J. (2012) Histoire naturelle de la dermatite atopique: ExpÉrience des cohortes néonatales. Revue Française d’Allergologie, 52, 168-174. https://doi.org/10.1016/j.reval.2012.01.008
[4]
Alexander, H., Paller, A.S., Traidl‐Hoffmann, C., Beck, L.A., De Benedetto, A., Dhar, S., et al. (2020) The Role of Bacterial Skin Infections in Atopic Dermatitis: Expert Statement and Review from the International Eczema Council Skin Infection Group. British Journal of Dermatology, 182, 1331-1342. https://doi.org/10.1111/bjd.18643
[5]
Cevikbas, F., Wang, X., Akiyama, T., Kempkes, C., Savinko, T., Antal, A., et al. (2014) Un récepteur d’IL-31 exprimé par un neurone sensoriel médie les démangeaisons dépendantes des cellules T auxiliaires: Implication de TRPV1 et TRPA1. Journal d’Allergie et d’Immunologie Clinique, 133, 448-460. https://doi.org/10.1016/j.jaci.2013.10.048
[6]
Barbarot, S. (2016) Physiopathologie de la dermatite atopique et perspective thérapeutiques systémiques. Réalités Thérapeutiques en Dermato-Vénérologie, 256, 48-50.
[7]
Sánchez, J., Sánchez, A. and Cardona, R. (2018) Critical Review of ISAAC Results for Atopic Dermatitis in Tropical Cities. Revista Alergia México, 65, 389-399. https://doi.org/10.29262/ram.v65i4.341
[8]
Dammak, A. and Guillet, G. (2011) Dermatite atopique de l’enfant. Journal de Pédiatrie et de Puériculture, 24, 84-102. https://doi.org/10.1016/j.jpp.2011.02.005
[9]
Jeon, C., Yan, D., Nakamura, M., Sekhon, S., Bhutani, T., Berger, T. and Liao, W. (2017) Frequency and Management of Sleep Disturbance in Adults with Atopic Dermatitis: A Systematic Review. Dermatology and Therapy, 7, 349-364. https://doi.org/10.1007/s13555-017-0192-3
[10]
Pefura-Yone, E.W., Sonkoue, L.D., Balkissou, A.D. and Djenabou, A. (2017) Prévalence et déterminants de la dermatite atopique chez les adultes en population générale dans un pays d’Afrique sub-saharienne. Revue Française d’Allergologie, 57, 240-241. https://doi.org/10.1016/j.reval.2017.02.077
[11]
Wisuthsarewong, W. and Viravan, S. (2004) Diagnostic Criteria for Atopic Dermatitis in Thai Children. Journal of the Medical Association of Thailand, 87, 1496-500.
[12]
Karima, N. (2015) Prévalence de la dermatite atopique. Thèse de doctorat, Université Cadi Ayyad de Marrakech.
[13]
Atadokpèdé, F., Yédomon, H., Adégbidi, H., Agbéssi, N., Soumah, H. and Diane, F. (2011) Aspects épidémiologiques de la dermatite atopique dans deux services de Dermatologie à Cotonou-Bénin. Guinée Médicale, 72, 1-5.
[14]
Nnoruka, E.N. (2004) Current Epidemiology of Atopic Dermatitis in South-Eastern Nigeria. International Journal of Dermatology, 43, 739-744. https://doi.org/10.1111/j.1365-4632.2004.02360.x
[15]
Leveque, C.J., Reguiai, Z., Fougerousse, A.C., Maccari, F., Badaoui, A., Esteve, E., et al. (2021) Description de la dermatite atopique de l’adulte, résultats de la cohorte DAPHNE. Annales de Dermatologie et de Vénéréologie-FMC, 1, A294-A295. https://doi.org/10.1016/j.fander.2021.09.318
[16]
Kharfi, M., BelHadjali, H., Khaled, A., Mokhtar, I. and Kamoun, M.R. (2001) Dermatite atopique. aspects épidemiologique et clinique. Annales de Dermatologie et de Venéréologie, 128, 597-693.
[17]
Fatima-ezzahra, B. (2018) La prevalence de la Dermatite atopique à la province de Béni-mellal. Thèse de Doctorat, Université de Marrakech.
[18]
Sendrasoa, F.A., Ramily, S.L., Razafimaharo, T.I., Ranaivo, I.M., Andrianarison, M., et al. (2021) Atopic Dermatitis in Adults: A Cross-Sectional Study in the Department of Dermatology, Antananarivo, Madagascar. Journal of the American Academy of Dermatology International, 4, 28-31. https://doi.org/10.1016/j.jdin.2021.04.001
[19]
Dupin, N. (2018) Item 183-UE 7 hypersensibilités et allergies cutanéo-muqueuses chez l’enfant et l’adulte. Annales de Dermatologie et de Venereologie, 145, S114-S130. https://doi.org/10.1016/j.annder.2018.01.023
[20]
Anis, M., Inès, Z., Thouraya, A., Hela, Z., Dalenda, E.E., Mourad, M. and et Amel, B.O. (2014) Dermatite atopique sévère de l’enfant. La Tunisie Medicale, 92, 249-252.
[21]
Misery, L. (2017) Burden of Atopic Dermatitis in Adults. Annales de Dermatologie et de Venereologie, 144, VS23-VS28. https://doi.org/10.1016/S0151-9638(18)30088-7
[22]
Derbré, S. and Launay, F. (2014) Place des thérapeutiques complémentaires et alternatives dans les dermatites atopiques. Actualités Pharmaceutiques, 53, 12-15. https://doi.org/10.1016/j.actpha.2013.12.022
[23]
Thomas, M. and Georg, A. (2023) Dermatite Atopique. University of Göttigan Germany.
[24]
Meylan, P., Lang, C., Mermoud, S., Johannsen, A., Norrenberg, S., Hohl, D., et al. (2017) Skin Colonization by Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic Dermatitis in Infancy. Journal of Investigative Dermatology, 137, 2497-2504. https://doi.org/10.1016/j.jid.2017.07.834
[25]
Phillips, Jr., R.L. and Koenig, C.J. (2000) Antihistamines for Atopic Dermatitis. The Journal of Family Practice, 49, Article 267.
[26]
Irvine, A.D. and McLean, W.I. (2006) Breaking the (Un)Sound Barrier: Filaggrin Is a Major Gene for Atopic Dermatitis. Journal of Investigative Dermatology, 126, 1200-1202. https://doi.org/10.1038/sj.jid.5700365
[27]
Velter, C., Lenormand, C. and Kluger, N. (2018) Dermatite atopique et maladies inflammatoires. Annales de Dermatologie et de Venereologie, 145, IS3-IS24. https://doi.org/10.1016/S0151-9638(18)30384-3
[28]
Yemaneberhan, H., Flohr, C., Lewis, S.A., Bekele, Z., Parry, E., Williams, H.C., et al. (2004) Prevalence and Associated Factors of Atopic Dermatitis Symptoms in Rural and Urban Ethiopia. Clinical & Experimental Allergy, 34, 779-785. https://doi.org/10.1111/j.1365-2222.2004.1946.x
[29]
Roul, S., Leaute-Labreze, C., Perromat, M., Ducombs, G. and Taieb, A. (2001) Sensitization to Cockroach Allergens Evaluated by Skin Tests in Children with Atopic Dermatitis. Annales de Dermatologie et de Venereologie, 128, 115-117.
[30]
Schmidt, S., Rainer, J., Ploner, C., Presul, E., Riml, S. and Kofler, R. (2004) Glucocorticoid-Induced Apoptosis and Glucocorticoid Resistance: Molecular Mechanisms and Clinical Relevance. Cell Death & Differentiation, 11, S45-S55. https://doi.org/10.1038/sj.cdd.4401456
[31]
Martins, J.C., Martins, C., Aoki, V., Gois, A.F., Ishii, H.A. and da Silva, E.M. (2015) Topical Tacrolimus for Atopic Dermatitis. Cochrane Database of Systematic Reviews, No. 7, CD009864. https://doi.org/10.1002/14651858.CD009864.pub2
[32]
Zeppa, L., Bellini, V. and Lisi, P. (2011) Atopic Dermatitis in Adults. Dermatitis, 22, 40-46. https://doi.org/10.2310/6620.2011.10042
